Bill Maughan
Stock Analyst at Clear Street
(0.23)
# 4,316
Out of 4,996 analysts
15
Total ratings
25%
Success rate
-27.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bill Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNTH Dianthus Therapeutics | Initiates: Buy | $100 | $36.71 | +172.41% | 1 | Sep 17, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $190 | $167.82 | +13.22% | 1 | Jul 1, 2025 | |
| CRSP CRISPR Therapeutics AG | Downgrades: Hold | $45 | $61.67 | -27.03% | 1 | Jun 27, 2025 | |
| NKTX Nkarta | Maintains: Buy | $16 → $15 | $2.04 | +635.29% | 2 | May 10, 2024 | |
| FATE Fate Therapeutics | Maintains: Buy | $11 → $9 | $1.00 | +800.00% | 1 | May 10, 2024 | |
| IMCR Immunocore Holdings | Maintains: Hold | $63 → $67 | $34.02 | +96.94% | 3 | May 9, 2024 | |
| MRNA Moderna | Maintains: Hold | $91 → $106 | $24.49 | +332.83% | 3 | May 3, 2024 | |
| IPSC Century Therapeutics | Maintains: Buy | $22 → $24 | $0.51 | +4,614.20% | 1 | Mar 15, 2024 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $60 | $7.40 | +711.36% | 1 | Feb 21, 2024 | |
| MRUS Merus | Initiates: Buy | $45 | $68.89 | -34.68% | 1 | Nov 2, 2023 |
Dianthus Therapeutics
Sep 17, 2025
Initiates: Buy
Price Target: $100
Current: $36.71
Upside: +172.41%
Krystal Biotech
Jul 1, 2025
Initiates: Buy
Price Target: $190
Current: $167.82
Upside: +13.22%
CRISPR Therapeutics AG
Jun 27, 2025
Downgrades: Hold
Price Target: $45
Current: $61.67
Upside: -27.03%
Nkarta
May 10, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.04
Upside: +635.29%
Fate Therapeutics
May 10, 2024
Maintains: Buy
Price Target: $11 → $9
Current: $1.00
Upside: +800.00%
Immunocore Holdings
May 9, 2024
Maintains: Hold
Price Target: $63 → $67
Current: $34.02
Upside: +96.94%
Moderna
May 3, 2024
Maintains: Hold
Price Target: $91 → $106
Current: $24.49
Upside: +332.83%
Century Therapeutics
Mar 15, 2024
Maintains: Buy
Price Target: $22 → $24
Current: $0.51
Upside: +4,614.20%
Bicycle Therapeutics
Feb 21, 2024
Reiterates: Buy
Price Target: $60
Current: $7.40
Upside: +711.36%
Merus
Nov 2, 2023
Initiates: Buy
Price Target: $45
Current: $68.89
Upside: -34.68%